Tonix Pharmaceuticals(us:TNXP)
0.4039
-33.96%
Updated on 2024-12-23
Open:0.5018
Close:0.4039
High:0.5297
Low:0.3960
Pre Close:0.6116
Volume:165.17M
Amount:75.83M
Turnover:88.37%
Shares:186.89M
MarketCap:75.49M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 42 | 327505 | 3.33% | 10 | 10 | 19 |
| 2024-03-31 | 49 | 375435 | 0.51% | 13 | 8 | 19 |
| 2023-12-31 | 40 | 14426062 | 24.61% | 9 | 10 | 6 |
| 2023-09-30 | 37 | 3694534 | 20.80% | 7 | 5 | 13 |
| 2023-06-30 | 36 | 1023350 | 9.51% | 4 | 19 | 9 |
| 2023-03-31 | 41 | 1212483 | 1.90% | 1 | 12 | 14 |
| 2022-12-31 | 55 | 9242088 | 12.08% | 10 | 8 | 22 |
| 2022-09-30 | 60 | 5574148 | 10.45% | 9 | 14 | 22 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Sabby Management, Llc | 152999 | 0.21% | 56260 | 58.16% |
| 2024-03-31 | Alyeska Investment Group, L.P. | 62500 | 0.08% | -21959 | -26.00% |
| 2024-03-31 | Marshall Wace, Llp | 50857 | 0.07% | -24143 | -32.19% |
| 2024-03-31 | Rosalind Advisors, Inc. | 28153 | 0.04% | 0 | |
| 2024-03-31 | Vanguard Group Inc | 16589 | 0.02% | 3919 | 30.93% |
| 2024-03-31 | Armistice Capital, Llc | 15281 | 0.02% | -102532 | -87.03% |
| 2024-03-31 | Geode Capital Management, Llc | 12460 | 0.02% | 9128 | 273.95% |
| 2024-03-31 | Acadian Asset Management Llc | 10480 | 0.01% | 7573 | 260.51% |
| 2024-03-31 | Prudential Financial Inc | 4213 | 0.01% | 4213 | |
| 2024-03-31 | Renaissance Technologies Llc | 3898 | 0.01% | -3650 | -48.36% |
About
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
Address:26 Main Street,Suite 101
Website:http://www.tonixpharma.com
Market Movers